Start for free
Start for free
SBI Japan-Israel Innovation Fund logo

SBI Japan-Israel Innovation Fund

Asia, Tel Aviv, Israel, Tel Aviv-yafo

Description

SBI JI Innovation Fund is a biopharma focused VC.

Investor Profile

SBI Japan-Israel Innovation Fund has made 9 investments, with 2 in the past 12 months and 11% as lead.

Stage Focus

  • Series B (56%)
  • Series C (22%)
  • Series A (11%)
  • Series D (11%)

Country Focus

  • Israel (78%)
  • United States (22%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Clinical Trials
  • Medical
  • Therapeutics
  • Genetics
  • Computer
  • Cyber Security
  • Identity Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SBI Japan-Israel Innovation Fund frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Sequoia Capital
Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 3
Seventure Partners
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
Andera Partners
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Bluestem Capital
Bluestem Capital
North America, South Dakota, United States, Sioux Falls
Co-Investments: 2
LV
LifeSci Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Visionary Venture Fund
Visionary Venture Fund
North America, California, United States, Aliso Viejo
Co-Investments: 3
Takeda Ventures
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2
Maverick Ventures
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does SBI Japan-Israel Innovation Fund often collaborate with?

PT
Peter Thiel
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by SBI Japan-Israel Innovation Fund?

Secret Double Octopus

Tel Aviv, Tel Aviv, Israel

Secret Double Octopus provides passwordless authentication solutions for enterprise.

ComputerCyber SecurityIdentity ManagementInternet of ThingsSoftware
Series COct 28, 2024
Orasis Pharmaceuticals

Ponte Vedra, Florida, United States

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.

Clinical TrialsHealth CareMedicalPharmaceutical
Series DOct 8, 2024
Amount Raised: $68,000,000
Orasis Pharmaceuticals

Herzliya, Tel Aviv, Israel

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Clinical TrialsHealth CareMedicalPharmaceutical
Series CSep 10, 2020
Amount Raised: $30,000,000
BIOMx

Ness Ziona, HaMerkaz, Israel

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

BiotechnologyHealth CareTherapeutics
Series BFeb 20, 2019
Amount Raised: $32,000,000
Biond Biologics

Misgav, HaZafon, Israel

Biond Biologics is an Israeli biotechnology discovery and development company.

BiotechnologyHealth CarePharmaceutical
Series BJan 8, 2019
Amount Raised: $17,000,000
Orasis Pharmaceuticals

Herzliya, Tel Aviv, Israel

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Clinical TrialsHealth CareMedicalPharmaceutical
Series BJun 5, 2018
Amount Raised: $13,000,000
Chemomab

Tel Aviv, Tel Aviv, Israel

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

BiotechnologyHealth CarePharmaceutical
Series BDec 4, 2017
Amount Raised: $10,000,000
LogicBio Therapeutics

Foster City, California, United States

LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.

BiotechnologyGenetics
Series BJun 29, 2017
Amount Raised: $45,000,000
BIOMx

Ness Ziona, HaMerkaz, Israel

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

BiotechnologyHealth CareTherapeutics
Series AMay 15, 2017
Amount Raised: $24,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator